Tue, Jul 22, 2014, 2:51 PM EDT - U.S. Markets close in 1 hr 9 mins

Recent

% | $
Click the to save as a favorite.

Greenlight Capital Re, Ltd. Message Board

better_eagle1 6 posts  |  Last Activity: Jun 4, 2014 11:18 AM Member since: Jul 20, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • There is no accounting issues with MHLD and likely none with ASFI either. The relationship between ASFI and MHLD is that ASFI is MHLD's reinsurer. In the very unlikely event that ASFI would fail, it would likely take MHLD with it. That's a low risk in my estimation. The fact that MHLD's management has stepped up and bought stock yesterday is encouraging. MHLD's is trading under a broken double top. Great opportunity for a mutual fund or hedge fund to get a great stock with a good dividend and strong earnings momentum to score big for their second quarter. Great short-squeeze candidate, too.

    Sentiment: Strong Buy

  • This guy is a knowledgeable analyst who follows ISRG. Please read his report.
    http://seekingalpha.com/article/2211623-is-intuitive-surgical-an-undervalued-stock-or-a-value-trap

    Sentiment: Strong Sell

  • better_eagle1 better_eagle1 May 15, 2014 4:04 PM Flag

    Please give the link to this news I can't find any news what-so-ever.

  • I have found no news or message boards that would indicate that any fundamental change has occurred with LSTMF. It appears to be fear driven selling based upon recouping past losses. Since embedded losses are huge with this stock, this problem will be with us every time the stock rises until it regains much higher levels than $6 per share. For new investors, this is a great turnaround story that should gain momentum; a good stock to buy on weakness. For existing investors with large losses: wait until this company gets institutional interest. Institutions will soon be able to buy this company when its debt is reduced. Otherwise, if existing holders are selling just to recoup some losses, it will delay the day that institutions send this stock to $9 and higher. HOLD ON and enjoy the ride. There is nothing to fear but fear itself!

    Sentiment: Strong Buy

  • David Einhorn was quoted yesterday saying Athena Medical was a big short. Shortly after, the last two days has been horrible for Anthera Pharmaceuticals. Is someone out there seriously confused???

    Sentiment: Strong Buy

  • Reply to

    Down 11% on conference call and earnings?

    by labrak2 Apr 23, 2014 3:10 PM
    better_eagle1 better_eagle1 Apr 24, 2014 11:18 AM Flag

    Irrational selling. The conference call was very positive for the intermediate long term buy negative for the short term. Short-term raw materials are going up and sales are down because of closing of Family Dollar stores. 2014 will likely be a difficult year due to a change of inventory system to just-in-time, higher raw materials costs, and more difficult sales. Intermediate will be positive as the company is going to protect the dividend and after the just-in-time inventory system is complete, costs will decline and margins will improve. Also, as Family Dollar consolidates to larger centralized stores, TIS will actually gain market share from FDS and increase sales as a preferred supplier. Longer-term the company revealed a regional to national footprint strategy for significant growth. To summarize, 2014 will be difficult, but investors will earn 5% from the dividend. After this year, I would expect to see significant gains in the 2015 to 2017 period. Traders may want to find the trading range and play it for 2015. Long-term investors should be initiating positions and adding on 2014 weakness. Weakness should occur from software glitches or sales disappointments during 2014. The current weakness is a buying opportunity for both traders and long-term investors. I have initiated a position withing the last 72 hours.

    Sentiment: Buy

GLRE
34.10-0.19(-0.55%)2:51 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.